• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Midlife smoking, diabetes, and hypertension associated with late life dementia

byShayna BejaimalandAnees Daud
August 11, 2017
in Cardiology, Chronic Disease, Endocrinology, Nephrology, Neurology, Psychiatry, Public Health, Surgery
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Based on results of the Atherosclerotic Risk in Communities (ARIC) prospective cohort, midlife vascular risk factors associated with dementia included smoking, diabetes, prehypertension, and hypertension.

2. Other risk factors associated with dementia included black race, older age, lower educational attainment, and APOE ε4 genotype.

Evidence Rating Level: 2 (Good)

Study Rundown: Vascular dementia is a common cause of cognitive decline in the elderly, thus control of vascular risk factors may decrease the prevalence of this disease. It is unknown how much vascular risk factors present in midlife contribute to late life risk of cognitive decline. This study examined data from the Atherosclerosis Risk in Communities (ARIC) cohort to explore associations between midlife vascular risk factors and 25-year dementia incidence.

Patient characteristics associated with increased risk of dementia at 25-years was black race, older age, lower educational attainment and APOE ε4 genotype. Midlife vascular risk factors associated with higher risk of dementia included smoking, diabetes, prehypertension, and hypertension. Strengths of this study included long-follow up time to measure outcomes. However, this study did not evaluate any effect of intervention on these midlife vascular risk factors, which warrants further study.

Click to read the study, published in JAMA Neurology

Relevant Reading: Midlife cardiovascular risk factors and risk of dementia in late life

RELATED REPORTS

#VisualAbstract: Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

Heavy smoking is associated with visual field loss in glaucoma

#VisualAbstract: Varenicline improves successful smoking cessation amongst African American daily smokers: KIS-IV Trial

In-Depth [prospective cohort]: This large-scale prospective cohort study was conducted using patient data from the Atherosclerosis Risk in Communities Study (1987-1989) and included healthy adults aged 44 to 66 years old. The exposure of interest included midlife vascular risk factors measured at baseline: obesity, smoking, diabetes, prehypertension, hypertension, hypercholesterolemia and APOE ε4 genotype. The outcome of interest was diagnosis of dementia after 25 years of follow-up as determined by detailed neurocognitive battery of tests, interviews, and adjudicated review. Statistical analysis included adjusted Cox proportional hazards regression.

Of 15 744 participants, 1516 cases of dementia were identified over the follow-up period. Patient characteristics associated with dementia were: black race (HR 1.36; 95%CI 1.21-1.54), older age 60-66 years (HR 8.06; 95%CI 6.69-9.72), lower educational attainment less than high school education (HR 1.61; 95%CI 1.28-2.03), and APOE ε4 genotype (HR1.98; 95%CI 1.78-2.21). Midlife vascular factors associated with dementia were: smoking (HR 1.41; 95%CI 1.23-1.61), diabetes (HR 1.77; 95%CI 1.53-2.04), prehypertension (HR 1.31; 95%CI 1.14-1.51) and hypertension (HR 1.39; 95%CI 1.22-1.59).

Image: CC/Wiki

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: dementiahypertensionsmoking
Previous Post

Levosimendan not effective in reducing postoperative low cardiac output syndrome in select heart surgery patients

Next Post

Antiretroviral therapy with tenofovir-emtricitabine-efavirenz demonstrates lower rate of adverse birth outcomes than other regimens

RelatedReports

#VisualAbstract: Varenicline improves successful smoking cessation amongst African American daily smokers: KIS-IV Trial
StudyGraphics

#VisualAbstract: Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

June 29, 2022
Smoking during pregnancy associated with aerobic fitness of children
Ophthalmology

Heavy smoking is associated with visual field loss in glaucoma

June 28, 2022
#VisualAbstract: Varenicline improves successful smoking cessation amongst African American daily smokers: KIS-IV Trial
StudyGraphics

#VisualAbstract: Varenicline improves successful smoking cessation amongst African American daily smokers: KIS-IV Trial

June 28, 2022
Genetic risk assessment for Alzheimer’s disease does not increase anxiety, depression or stress
Chronic Disease

Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

June 17, 2022
Next Post
No link between cesarean delivery and BMI in later childhood

Antiretroviral therapy with tenofovir-emtricitabine-efavirenz demonstrates lower rate of adverse birth outcomes than other regimens

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription

PCSK9 inhibitors unlikely to be cost-effective

2 Minute Medicine Rewind August 14, 2017

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Lisocabtagene maraleucel improves survival for relapsed or refractory large B-cell lymphoma
  • Fazirsiran reduces Z-AAT protein production in alpha1-antitrypsin deficiency
  • Arterial chemoembolization improves survival in non-resectable hepatocellular carcinoma [Classics Series]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.